1-3 of 3
Steffen Koschmieder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germline variants in DNA repair genes, including BRCA1 / 2 , may cause familial myeloproliferative neoplasms

Clinical Trials & Observations
Miriam Elbracht, Robert Meyer, Kim Kricheldorf, Deniz Gezer, Eggermann Thomas, Beate Betz, Ingo Kurth, Lino L. Teichmann, Tim H. Brümmendorf, Ulrich Germing, Susanne Isfort, Steffen Koschmieder
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3373–3376.
https://doi.org/10.1182/bloodadvances.2021004811
Published: 2021
Journal Articles

Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study

Clinical Trials & Observations
Vikas Gupta, Denise Wolleschak, Hans Hasselbalch, Alessandro Maria Vannucchi, Steffen Koschmieder, Francisco Cervantes, Yang Li, Tuochuan Dong, Monika Wroclawska, Savita Bharathy, Claire Harrison
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3063–3071.
https://doi.org/10.1182/bloodadvances.2019001212
Published: 2020
Includes: Supplemental data
Journal Articles

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia

Anne-Sophie Bouillon, Monica S. Ventura Ferreira, Shady Adnan Awad, Johan Richter, Andreas Hochhaus, Volker Kunzmann, Jolanta Dengler, Jeroen Janssen, Gert Ossenkoppele, Peter E. Westerweel, Peter A. W. te Boekhorst, Francois-Xavier Mahon, Henrik Hjorth-Hansen, Susanne Isfort, Thoas Fioretos, Sebastian Hummel, Mirle Schemionek, Stefan Wilop, Steffen Koschmieder, Susanne Saußele, Satu Mustjoki, Fabian Beier, Tim H. Brümmendorf
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1572–1579.
https://doi.org/10.1182/bloodadvances.2018017772
Published: 2018
Includes: Supplemental data